As published in a report in 2009 call “Science and Decisions: Advancing Risk Assessment,” the NRC suggest that, in considering population-level genetic variability, the low-dose region of non-cancer dose-response relationships will linearize. As such, the NRC recommends that there are no safe exposures of chemicals that induced adverse, non-cancer endpoints.